Bucillamine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

7 API Suppliers, 3 USDMF, 4 JDMF, 1 KDMF, 1 Listed Suppliers

DEVELOPMENTS

48 Drug(s) in Development

48 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

1 Dossiers, 1 Listed Dossiers

DIGITAL CONTENT

37 News

37 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

Yonezawa Hamari Chemicals, Ltd.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Japan

Virtual Booth

Digital Content

Bushramin

PDF Supplier PDF

URL Supplier Web Content

Registrant Name

Chong Kun Dang Co., Ltd.

Registration Date

2005-08-31

Registration Number

20050831-15-C-89-02

Manufacturer

HAMARI PFST, Ltd.

Manufacturer’s Country

Japan

Manufacturer’s Address

2-4300-18, Hachimampara, ...

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 65002-17-7 / Bucillamine API manufacturers, exporters & distributors?

PharmaCompass offers a list of Bucillamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Bucillamine manufacturer or Bucillamine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bucillamine manufacturer or Bucillamine supplier.

PharmaCompass also assists you with knowing the Bucillamine API Price utilized in the formulation of products. Bucillamine API Price is not always fixed or binding as the Bucillamine Price is obtained through a variety of data sources. The Bucillamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Bucillamine

Synonyms

65002-17-7, Tiobutarit, Rimatil, N-(2-mercapto-2-methylpropionyl)-l-cysteine, Thiobutarit, Bucilant

Cas Number

65002-17-7

Unique Ingredient Identifier (UNII)

R80LRA5WTF

About Bucillamine

Bucillamine is an orally bioavailable derivative of the endogenous amino acid cysteine with two donatable thiol groups, with potential antioxidant and anti-inflammatory activities. Upon oral administration, bucillamine enters cells rapidly via the same pathway as cysteine and replenishes the thiol group in glutathione (GSH), thereby increasing intracellular GSH levels and GSH activity. GSH is an antioxidant and plays an important protective role in oxidative stress and injury. Bucillamine may have additional anti-inflammatory effects, though the mechanisms of action have yet to be fully elucidated.

Bucillamine Manufacturers

A Bucillamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bucillamine, including repackagers and relabelers. The FDA regulates Bucillamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bucillamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Bucillamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Bucillamine Suppliers

A Bucillamine supplier is an individual or a company that provides Bucillamine active pharmaceutical ingredient (API) or Bucillamine finished formulations upon request. The Bucillamine suppliers may include Bucillamine API manufacturers, exporters, distributors and traders.

click here to find a list of Bucillamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Bucillamine KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Bucillamine Drug Master File in Korea (Bucillamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bucillamine. The MFDS reviews the Bucillamine KDMF as part of the drug registration process and uses the information provided in the Bucillamine KDMF to evaluate the safety and efficacy of the drug.

After submitting a Bucillamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bucillamine API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Bucillamine suppliers with KDMF on PharmaCompass.

Bucillamine Manufacturers | Traders | Suppliers

We have 1 companies offering Bucillamine

Get in contact with the supplier of your choice:

Yonezawa Hamari Chemicals, Ltd.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.